Altria Client Services LLC has issued a public comment to the U.S. Food and Drug Administration (FDA)’s ANPRM on the Regulation of Premium Cigars requesting a 90-day extension to the public comment period. The comment was submitted on behalf of Philip Morris USA Inc., John Middleton Company (“JMC”), and Sherman Group Holdings LLC and its […]
On Special Edition #27, we return to some hard-core industry talk as we welcome Todd Naifeh of ZT Cigars as our special guest. We will learn about Todd’s retail operation out of Oklahoma City, but we will also get some insights into his role on the current IPCPR board of directors. The U.S. Food and Drug […]
On March 26th, 2018, the long-awaited Advanced Notice of Public Rule Making (ANPRM) in regards to premium cigars was published by the U.S. Food and Drug Administration (FDA). It’s a document that paints the picture in terms of what the FDA is thinking – namely how or if it should regulate premium cigars. As a part […]
Back in January came word that a group of cigar-related businesses in Texas had filed a lawsuit against the U.S. Food and Drug Administration (FDA) challenging Warning Labels requirements. This past week, the group has motioned the court to throw out the current Warning Label requirements that are a part of the Deeming Regulations. Meanwhile, […]
In the latest round of the cigar industry’s lawsuit against the U.S. Food and Drug Administration (FDA), the three plaintiffs have motioned the court to throw out the current Warning Label requirements that are a part of the Deeming Regulations. The move comes a little over a week after the FDA issued an Advanced Noticed […]
Seven health groups are not happy that the U.S. Food and Drug Administration has delayed the pre-market approval process on e-cigarettes and other tobacco products, including cigars. They have now gone to court in hopes of expediting the process again. Today a lawsuit was filed jointly by the American Academy of Pediatrics and its Maryland […]
Last week, the long-awaited Advanced Notice of Public Rule Making (ANPRM) in regards to premium cigars was officially announced by the U.S. Food and Drug Administration. On March 26th, 2018 the ANPRM was published in the Federal Register. It’s a document that paints the picture in terms of what the FDA is thinking – namely […]
Dr. Gaby Kafie, owner and founder of Kafie 1901 Cigars, has authored a letter to U.S. Food and Drug Administration Commissioner Dr. Scott Gottlieb in regards to nicotine levels in cigars. The letter is a response to the recent Advanced Notice of Public Rule Making (ANPRM) in terms of maximum nicotine levels. In the ANPRM, […]
It never fails. As I embark on travel, complete chaos seems to reign supreme in the cigar industry. Just when I thought a new level of chaos was reached with two cigar companies getting acquired in one day – along comes the week of March 18th to top it all. With this particular week, it […]
The long-awaited Advanced Notice of Proposed Rule Making (ANPRM) by the U.S. Food and Drug Administration (FDA) regarding premium cigars was released into draft today. This ANPRM begins the period where the FDA is officially beginning the process of re-evaluating how (or if) premium cigars should be regulated. An ANPRM seeking comments, data, research results, […]
